What is the step-by-step procedure for performing a greater occipital nerve block using lidocaine injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Greater Occipital Nerve Block Procedure with Lidocaine

For a greater occipital nerve block using lidocaine, use 1-3 mL of 0.5-2% lidocaine (without epinephrine, maximum 4.5 mg/kg or 300 mg total) injected bilaterally at the medial third of the distance between the external occipital protuberance and mastoid process, ideally under ultrasound guidance. 1

Pre-Procedure Preparation

Patient Assessment & Consent

  • Verify diagnosis (occipital neuralgia, migraine, cluster headache)
  • Calculate ideal body weight for dosing: (height in cm - 100) for men; (height in cm - 105) for women 2
  • Confirm no contraindications: cardiac disease, seizure disorders, hepatic/renal impairment, allergy to local anesthetics 2
  • Obtain informed consent explaining risks of local anesthetic toxicity (tingling tongue/lips, tinnitus, light-headedness progressing to seizures, cardiac arrhythmias) 2

Equipment & Medication Setup

  • Lidocaine concentration: 0.5-2% solution without epinephrine 1, 3, 4
  • Maximum dose: 4.5 mg/kg ideal body weight, not exceeding 300 mg total 1
  • Volume per side: 1-3 mL (typically 2 mL per greater occipital nerve) 4
  • Ultrasound machine with 7-13 MHz linear transducer (if using ultrasound guidance) 3, 5
  • 25-27 gauge needle
  • Antiseptic solution
  • Emergency equipment: lipid emulsion 20%, resuscitation cart 2

Step-by-Step Injection Technique

1. Patient Positioning

  • Seated or prone position with neck slightly flexed
  • Expose occipital region from external occipital protuberance to mastoid processes bilaterally

2. Anatomical Landmark Identification

Without ultrasound (traditional blind technique):

  • Palpate external occipital protuberance (EOP)
  • Palpate mastoid process
  • Injection site: Medial third of the distance between EOP and mastoid process (approximately 20-23 mm lateral to EOP) 5
  • Palpate for occipital artery pulsation (nerve typically lies 1-1.5 mm from artery) 5

With ultrasound guidance (preferred method):

  • Place linear transducer transversely at base of skull
  • Identify occipital artery with color Doppler
  • Visualize greater occipital nerve as hypoechoic oval structure adjacent to artery 3, 5
  • Depth: Nerve typically 6-7 mm below skin surface 5
  • Consider using 0.1 mL contrast if fluoroscopy available 6

3. Injection Procedure

Bilateral injection sequence:

  • Prepare skin with antiseptic
  • Insert needle perpendicular to skin or with slight medial angulation
  • Advance to depth of 6-8 mm (until contact with periosteum or nerve visualization) 5
  • Aspirate before injection to avoid intravascular injection
  • Inject 2 mL of lidocaine slowly per side 4
  • Total volume: 4 mL for bilateral block
  • Withdraw needle and apply pressure

4. Post-Injection Monitoring

Immediate (first 20 minutes):

  • Monitor for signs of local anesthetic toxicity: tingling tongue/lips, metallic taste, tinnitus, dizziness 2
  • Assess sensory blockade in occipital distribution
  • Document pain reduction using visual analog scale 3, 4

Expected outcomes:

  • Pain relief typically begins within 5-20 minutes 3, 4
  • Duration: 1-4 weeks with lidocaine alone 6, 4
  • Complete sensory block rate: 77% with ultrasound guidance vs 31% with blind technique 5, 7

Critical Safety Considerations

Absolute Contraindications to Concurrent Use

Do NOT perform this nerve block if:

  • Patient received IV lidocaine within 4 hours 2
  • Patient has other local anesthetic blocks active (wait 4 hours after their completion) 2
  • Patient weight <40 kg 2

Toxicity Recognition & Management

Progressive symptoms with increasing plasma levels 2:

  • Early: Tingling tongue/lips, light-headedness, tinnitus
  • Moderate: Slurred speech, muscle twitching
  • Severe: Loss of consciousness, respiratory arrest, seizures, cardiac arrhythmias, ventricular arrest

If toxicity occurs: Administer lipid emulsion 20% per ACLS guidelines, provide supportive care 2

Technical Pearls

  • Ultrasound guidance increases success rate from 31% to 77% and provides longer pain relief (group S: VAS 2.3 at 4 weeks vs group B: VAS 3.8) 5
  • Avoid injecting directly into occipital artery (use Doppler to identify) 7
  • Bilateral blocks more effective than unilateral for bilateral symptoms 4
  • Consider adding steroid (triamcinolone 40 mg) for longer duration, though evidence shows minimal additional benefit over lidocaine alone 4
  • For refractory cases, 10% lidocaine neurolysis may extend relief to 148 days (requires specialized training and fluoroscopic guidance) 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.